Lexicon Pharmaceuticals, INC. (LXRX) SEC Filings — 2024
25 SEC filings for Lexicon Pharmaceuticals, INC. (LXRX) in 2024.
Filings
- Invus Group Amends Lexicon Pharma Stake Filing — SC 13D/A · Dec 9, 2024
- Lexicon Pharma Reports Exit/Disposal Costs — 8-K · Nov 22, 2024
- Lexicon Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Nov 20, 2024
- Lexicon Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Lexicon Pharmaceuticals Q3 Expenses Decline — 10-Q · Nov 13, 2024
- Lexicon Pharmaceuticals Files 8-K on Financials — 8-K · Nov 12, 2024
- Lexicon Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Lexicon Pharmaceuticals Enters Material Definitive Agreement — 8-K · Oct 16, 2024
- Lexicon Pharma Appoints New Chief Medical Officer — 8-K · Sep 16, 2024
- Lexicon Pharmaceuticals, INC. 10-Q Filing — 10-Q · Aug 2, 2024
- Lexicon Pharmaceuticals Files 8-K on Financials — 8-K · Aug 1, 2024
- Invus L.P. Amends Lexicon Pharmaceuticals Stake Filing — SC 13D/A · Jul 29, 2024
- Lexicon Pharmaceuticals, INC. SC 13G Filing — SC 13G · Jul 10, 2024
- Lexicon Pharma Appoints New Chief Medical Officer — 8-K · Jul 8, 2024
- Lexicon Pharmaceuticals Enters Material Definitive Agreement — 8-K · Jul 1, 2024
- Invus L.P. Amends Lexicon Pharmaceuticals Stake — SC 13D/A · May 14, 2024
- Lexicon Pharmaceuticals Files 8-K with Equity, Bylaw, and Shareholder Votes — 8-K · May 10, 2024
- Lexicon Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Lexicon Pharmaceuticals Announces CMO Retirement and Appointment — 8-K · Apr 29, 2024
- Lexicon Pharmaceuticals Announces 2024 Annual Meeting of Stockholders — DEF 14A · Mar 26, 2024
- Lexicon Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 25, 2024
- Invus L.P. Amends Stake in Lexicon Pharmaceuticals — SC 13D/A · Mar 13, 2024
- Lexicon Pharmaceuticals Files 8-K on Corporate Changes — 8-K · Mar 12, 2024
- Lexicon Pharmaceuticals Announces Material Agreement & Financial Updates — 8-K · Mar 11, 2024
- Lexicon Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024